Variant report
Variant | nsv605233 |
---|---|
Chromosome Location | chr6:165004614-165045334 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:165007452..165009387-chr6:165042540..165044932,2 | K562 | blood: | |
2 | chr6:165029398..165031412-chr6:165033183..165034759,2 | K562 | blood: | |
3 | chr6:164768274..164768906-chr6:165033273..165034147,2 | MCF-7 | breast: | |
4 | chr6:165007452..165009387-chr6:165042540..165044932,2 | K562 | blood: | |
5 | chr6:165029398..165031412-chr6:165033183..165034759,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184587825 | chr6:165016003-165016004 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2055261 | chr6:165016007-165016008 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs551996426 | chr6:165016015-165016016 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144804248 | chr6:165016081-165016082 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534008394 | chr6:165016090-165016091 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188449835 | chr6:165016093-165016094 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147943034 | chr6:165016100-165016101 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373671848 | chr6:165016108-165016109 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192279027 | chr6:165016119-165016120 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141638225 | chr6:165016150-165016151 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576206612 | chr6:165016190-165016191 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs535259622 | chr6:165016204-165016205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs729034 | chr6:165016255-165016256 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs184612722 | chr6:165016287-165016288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541121097 | chr6:165016329-165016330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536841259 | chr6:165016367-165016368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564107376 | chr6:165016401-165016402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577522157 | chr6:165016402-165016403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371395162 | chr6:165016440-165016441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs729035 | chr6:165016455-165016456 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs563008100 | chr6:165016496-165016497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143715330 | chr6:165016560-165016561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533224418 | chr6:165016567-165016568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548403263 | chr6:165016576-165016577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561943489 | chr6:165016577-165016578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576381800 | chr6:165016578-165016579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113353267 | chr6:165016640-165016641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535734485 | chr6:165016644-165016645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs151024446 | chr6:165016692-165016693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140948622 | chr6:165016712-165016713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554450421 | chr6:165016716-165016717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570515093 | chr6:165016726-165016727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190295373 | chr6:165016777-165016778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150367373 | chr6:165016787-165016788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs376822427 | chr6:165016792-165016793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2047282 | chr6:165016833-165016834 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs12664018 | chr6:165016903-165016904 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192419494 | chr6:165017017-165017018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184967566 | chr6:165017018-165017019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188899306 | chr6:165017034-165017035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557861107 | chr6:165017078-165017079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2132414 | chr6:165017092-165017093 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs555634569 | chr6:165017115-165017116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562302381 | chr6:165017127-165017128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543086279 | chr6:165017166-165017167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181600593 | chr6:165017171-165017172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138113300 | chr6:165017393-165017394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141142936 | chr6:165017444-165017445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561955622 | chr6:165017465-165017466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186344677 | chr6:165017468-165017469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian cancer | 22355333 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:165016000-165016200 | ZNF genes & repeats | Pancreas | Pancrea |
2 | chr6:165016000-165016400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr6:165016400-165016800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:165016600-165017000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr6:165016800-165017000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr6:165016800-165017000 | ZNF genes & repeats | Pancreas | Pancrea |
7 | chr6:165017000-165020600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr6:165029000-165029400 | Enhancers | Brain Germinal Matrix | brain |
9 | chr6:165029400-165029800 | Weak transcription | Brain Germinal Matrix | brain |
10 | chr6:165029800-165030600 | Enhancers | Brain Germinal Matrix | brain |
11 | chr6:165031000-165031800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:165033000-165033200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr6:165033200-165033800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr6:165033400-165034600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr6:165033800-165034000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr6:165033800-165039000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr6:165039000-165039200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr6:165039800-165040200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr6:165039800-165041200 | Enhancers | Brain Substantia Nigra | brain |
20 | chr6:165040000-165040800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr6:165040000-165040800 | Enhancers | Brain Hippocampus Middle | brain |
22 | chr6:165040800-165043000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr6:165043000-165043600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |